Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
Background Liver regulates lipid metabolism in health and disease states. Nevertheless, the
entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism …
entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism …
Effects of turmeric on homocysteine and fetuin-A in patients with nonalcoholic fatty liver disease: A randomized double-blind placebo-controlled study
Background: Elevated levels of HOMOCYSTEINE (Hcy) and FETUIN-A are important risk
factors for cardiovascular diseases in patients with a NONALCOHOLIC FATTY LIVER …
factors for cardiovascular diseases in patients with a NONALCOHOLIC FATTY LIVER …
Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography
S Ballestri, E Meschiari, E Baldelli… - Metabolic Syndrome …, 2013 - liebertpub.com
Background: Nonalcoholic fatty liver disease (NAFLD) patients are prone to coronary artery
disease (CAD). Fetuin-A inhibits arterial calcification, induces insulin resistance, and is …
disease (CAD). Fetuin-A inhibits arterial calcification, induces insulin resistance, and is …
Клинико-диагностическое значение изменений толстой кишки при хроническом простатите
ВМ Попков - Саратовский научно-медицинский журнал, 2010 - cyberleninka.ru
Цель работы изучить клинико-микробиологические и морфологические характеристики
толстой кишки у больных хроническим простатитом, определить на основе полученных …
толстой кишки у больных хроническим простатитом, определить на основе полученных …